Juan A. Puente-Pineda

Mr. Juan A. Puente-Pineda

Centro de Investigación Biomédica (CENBIO), Universidad UTE, Quito, Pichincha, Ecuador
orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 May 2025 in Nutrients
Verified
Journal Article
Open access
PDF file
Carlos Barba-OstriaCarlos Barba-Ostria
Carlos Barba-Ostria
JGJessica Maritza Guamán-Bautista
Jessica Maritza Guamán-Bautista
ATAugusto Andrés Tosi
Augusto Andrés Tosi
Juan A. Puente-PinedaJuan A. Puente-Pineda
Juan A. Puente-Pineda
Melanie Aylin Cedeño ZambranoMelanie Aylin Cedeño Zambrano
Melanie Aylin Cedeño Zambrano
Linda GuamanLinda Guaman
Linda Guaman
Background: Andean plants are rich in bioactive compounds shaped by extreme environmental conditions, contributing to their antioxidant, antimicrobial, and anti-inflammatory properties. This review explores their phytochemical composition, biological activities, and therapeutic potential in modern medicine and nutrition of three plants of Andean origin. Methods: A literature review of peer-reviewed studies was conducted, focusing on key species such as quinoa (Chenopodium quinoa), amaranth (Amaranthus spp.), and lupin (Lupinus spp.), selected for this review due to their Andean origin, long-standing role in traditional diets, and growing scientific interest in their unique phytochemical profiles and therapeutic potential. This analysis covers their phytochemistry, bioactivities, and the influence of environmental factors on compound potency. Results: These Andean-origin plants contain flavonoids, terpenoids, alkaloids, and phenolic compounds that support antioxidant, antimicrobial, anti-inflammatory, and anticancer activities. High-altitude conditions enhance the biosynthesis of these bioactives, increasing their therapeutic value. Quinoa, amaranth, and lupin show strong potential for dietary and pharmaceutical applications, particularly in metabolic health and disease prevention. Additionally, preclinical studies and clinical trials have begun exploring the efficacy of these compounds in preventing and treating metabolic and chronic diseases. Conclusions: Andean plants are a valuable source of functional bioactive molecules with diverse health benefits. Future research should optimize cultivation strategies and explore novel applications in nutrition and medicine.

24 May 2024 in Frontiers in Bioengineering and Biotechnology
Verified
Journal Article
Open access
Saskya CarreraSaskya Carrera
Saskya Carrera
AMAlexander Mueller
Alexander Mueller
Juan A. Puente-PinedaJuan A. Puente-Pineda
Juan A. Puente-Pineda
JZJohana Zúñiga-Miranda
Johana Zúñiga-Miranda
LGLinda P. Guamán
Linda P. Guamán
Cancer is a significant global socioeconomic burden, as millions of new cases and deaths occur annually. In 2020, almost 10 million cancer deaths were recorded worldwide. Advancements in cancer gene therapy have revolutionized the landscape of cancer treatment. An approach with promising potential for cancer gene therapy is introducing genes to cancer cells that encode for chemotherapy prodrug metabolizing enzymes, such as Cytochrome P450 (CYP) enzymes, which can contribute to the effective elimination of cancer cells. This can be achieved through gene-directed enzyme prodrug therapy (GDEPT). CYP enzymes can be genetically engineered to improve anticancer prodrug conversion to its active metabolites and to minimize chemotherapy side effects by reducing the prodrug dosage. Rational design, directed evolution, and phylogenetic methods are some approaches to developing tailored CYP enzymes for cancer therapy. Here, we provide a compilation of genetic modifications performed on CYP enzymes aiming to build highly efficient therapeutic genes capable of bio-activating different chemotherapeutic prodrugs. Additionally, this review summarizes promising preclinical and clinical trials highlighting engineered CYP enzymes’ potential in GDEPT. Finally, the challenges, limitations, and future directions of using CYP enzymes for GDEPT in cancer gene therapy are discussed.

12 November 2025 in Antioxidants
Verified
Journal Article
Open access
PDF file
Elena Del Rocío Coyago CruzElena Del Rocío Coyago Cruz
Elena Del Rocío Coyago Cruz
RGRebeca Gonzalez-Pastor
Rebeca Gonzalez-Pastor
GMGabriela Inés Méndez
Gabriela Inés Méndez
Mateo Xavier Moya-CoyagoMateo Xavier Moya-Coyago
Mateo Xavier Moya-Coyago
Juan A. Puente-PinedaJuan A. Puente-Pineda
Juan A. Puente-Pineda
JHJorge Heredia-Moya
Jorge Heredia-Moya
Gleichenella pectinata, known as ‘Star fern’, is a species traditionally used by Amazonian indigenous communities to treat various diseases. The objective of this study was to evaluate the bioactive compounds and antioxidant, antimicrobial, antitumor, and anti-inflammatory activities of G. pectinata leaves. The study included the determination of physicochemical parameters (pH, soluble solids, titratable acidity, moisture, and ash), phytochemical screening, mineral analysis by atomic absorption and quantification of bioactive compounds (vitamin C, organic acids, carotenoids, chlorophylls, and phenols) by liquid chromatography (RRLC). Antioxidant (ABTS and DPPH), antimicrobial (ATCC bacteria and fungi, and multi-resistant strains), antitumor and anti-inflammatory activities were evaluated. The results showed the presence of acetogenins, high concentrations of malic acid (56,559.7 mg/100 g DW), β-carotene (266.6 mg/100 g DW), chlorophyll b (684.7 mg/100 g DW), ferulic acid (3163.5 mg/100 g DW) and quercetin glucoside (945.9 mg/100 g DW). The freeze-dried ethanolic extracts showed greater efficacy against Pseudomonas aeruginosa ATCC (12.0 mg/mL) and multidrug-resistant strains of E. coli (6.6 mg/mL) and P. aeruginosa (6.6 mg/mL). In addition, the extract exhibited moderate antiproliferative activity (IC50: 0.98–1.98 mg/mL) in hepatocellular and cervical carcinoma cell lines. In conclusion, this study provides the first evidence of the antitumor and bioactive potential of G. pectinata, supporting its value as a natural source of functional compounds with potential pharmacological applications.

29 October 2025 in Antioxidants
Verified
Journal Article
Open access
PDF file
Elena Del Rocío Coyago CruzElena Del Rocío Coyago Cruz
Elena Del Rocío Coyago Cruz
RGRebeca Gonzalez-Pastor
Rebeca Gonzalez-Pastor
GMGabriela Inés Méndez
Gabriela Inés Méndez
JUJeico Usinia-Carranza
Jeico Usinia-Carranza
Juan A. Puente-PinedaJuan A. Puente-Pineda
Juan A. Puente-Pineda
JHJorge Heredia-Moya
Jorge Heredia-Moya
The Amazon region is home to a wide variety of plant species that are of interest for their medicinal and nutritional properties. This study aimed to evaluate the physicochemical properties, bioactive compound profile, and antioxidant, antimicrobial, anticancer and anti-inflammatory activity of Dimerocostus strobilaceus leaves, stems, and seeds. Vitamin C, organic acids, carotenoids, and phenolic compounds were quantified using RPLC. Antioxidant activity was determined using ABTS and DPPH, while antimicrobial activity was assessed against pathogenic and multidrug-resistant bacteria. Anticancer activity was evaluated in tumour cell lines (HeLa, HCT116, HepG2, and THJ29T), and anti-inflammatory activity was examined in RAW 264.7 macrophages. The seeds stood out for their content of ferulic, caffeic and chlorogenic acids, while kaempferol and quercetin predominated in the leaves. The leaves exhibited greater antimicrobial efficacy and antiproliferative activity (IC50 < 0.2 mg/mL), albeit with limited selectivity. These findings suggest that ‘caña agria’ is a promising source of bioactive metabolites with biotechnological and therapeutic applications.

1 November 2026 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
Carlos Barba-OstriaCarlos Barba-Ostria
Carlos Barba-Ostria
Melanie Aylin Cedeño ZambranoMelanie Aylin Cedeño Zambrano
Melanie Aylin Cedeño Zambrano
Juan A. Puente-PinedaJuan A. Puente-Pineda
Juan A. Puente-Pineda
BZBelén Rebeca Cortez Zambrano
Belén Rebeca Cortez Zambrano
JGJessica Maritza Guamán-Bautista
Jessica Maritza Guamán-Bautista
Linda GuamanLinda Guaman
Linda Guaman
Antimicrobial resistance (AMR) and biofilm-associated infections represent major therapeutic challenges because they reduce antimicrobial susceptibility, promote persistence, and limit the effectiveness of conventional treatments. Phytochemicals offer a complementary strategy due to their multitarget antimicrobial and antibiofilm activities, including membrane disruption, oxidative stress induction, quorum-sensing interference, efflux-pump inhibition, and disruption of extracellular polymeric substances. However, their clinical application is frequently restricted by poor aqueous solubility, chemical instability, rapid degradation, limited bioavailability, and insufficient accumulation at infection sites. Encapsulation provides a means to overcome these limitations through physicochemical protection, controlled release, and improved local delivery. This review examines the main delivery platforms used to formulate antibacterial phytochemicals against multidrug-resistant and biofilm-associated bacterial pathogens, with emphasis on how carrier materials and formulation parameters influence antimicrobial and antibiofilm activity. Translational applications in antimicrobial coatings, medical devices, wound and burn infections, and combination therapies are critically discussed. Current limitations related to manufacturing scalability, reproducibility, safety, regulatory classification, methodological heterogeneity, and the limited progression from in vitro studies to clinically relevant models are also discussed. Overall, encapsulation can expand the therapeutic potential of phytochemicals, but future progress will depend on demonstrating reproducible advantages over free compounds through standardized formulation, appropriate controls, relevant preclinical models, and early integration of safety and regulatory requirements.

31 October 2025 in Molecules
Verified
Journal Article
Open access
PDF file
ARArianna Mayorga Ramos
Arianna Mayorga Ramos
RGRebeca Gonzalez-Pastor
Rebeca Gonzalez-Pastor
Juan A. Puente-PinedaJuan A. Puente-Pineda
Juan A. Puente-Pineda
Carlos Barba-OstriaCarlos Barba-Ostria
Carlos Barba-Ostria
ETEduardo Tejera
Eduardo Tejera
Linda GuamanLinda Guaman
Linda Guaman
The Ericaceae family encompasses several berries with recognized health-promoting properties; however, Macleania rupestris, a neotropical species endemic to the Andean region, remains poorly characterized. Background/Objectives: This study aimed to identify the chemical composition of M. rupestris ethanolic extracts and evaluate their biological activities, including antitumoral, hemolytic, anti-inflammatory, and leishmanicidal effects. Methods: The M. rupestris ethanolic extracts were obtained from lyophilized fruits and analyzed by HPLC-MS/MS for phytochemical profiling. Bioactivities were assessed in vitro using tumor and non-tumor cell lines (MTT assay), erythrocyte hemolysis assays, RAW 264.7 macrophage inflammation models, and Leishmania mexicana promastigotes. Results: The chemical analysis revealed anthocyanins (cyanidin-3-glucoside, malvidin-3-glucoside, petunidin-3-glucoside, delphinidin-3-arabinoside), flavonols (quercetin and myricetin derivatives), and coumaroyl iridoids. The extract showed modest antiproliferative activity (IC50 10.4–22.5 mg/mL) across tumor cell lines with low therapeutic indices, indicating limited selectivity. In contrast, hemolytic activity was negligible (<5% at all tested concentrations), suggesting high biocompatibility. Anti-inflammatory assays indicated a dose-dependent reduction in nitric oxide (NO) production, while no significant leishmanicidal activity was detected. Conclusions: This study provides the first comprehensive evaluation of the previously listed M. rupestris bioactivities. While its antitumoral effects appear limited, its strong hemocompatibility and presence of antioxidant metabolites highlight its potential for biomedical and nutraceutical applications where biocompatibility is critical. Further studies are needed to optimize bioactivity and explore potential synergistic effects.